Dutasteride PCD Pharma Franchise Company
Cafoli Lifecare offers a targeted Dutasteride PCD pharma franchise built on 5 formulations across capsules and tablets, all produced at WHO-GMP certified facilities. This gives franchise partners a well-defined urology and men's-health line for urologists and physicians.
What is Dutasteride?
Dutasteride is a dual 5-alpha-reductase inhibitor that blocks both type 1 and type 2 isoenzymes, lowering dihydrotestosterone (DHT) levels more completely than finasteride. It is used to treat benign prostatic hyperplasia (BPH) and, in combination products, male pattern hair loss. Read its profile on MedlinePlus.
Therapeutic Applications
Dutasteride is prescribed to shrink an enlarged prostate, relieve BPH symptoms and reduce the risk of acute urinary retention, and is used off-label and in combination with tamsulosin or minoxidil for androgenetic alopecia. Prescriptions come mainly from urologists, general physicians and dermatologists.
Why Dutasteride is a High-Potential Molecule for Distributors
BPH is a progressive condition of ageing men, and India's expanding elderly population steadily enlarges the patient pool. Because dutasteride is taken indefinitely to control prostate size, each patient represents a long, uninterrupted repeat-prescription stream. Its added role in hair-loss combinations opens a second, younger market — giving distributors both a chronic-care and a lifestyle channel from one molecule.
Why Choose Cafoli Lifecare
Cafoli Lifecare provides territory-wise monopoly rights, WHO-GMP certified manufacturing, DCGI-approved formulations, complete promotional inputs and the backing of 1000+ franchise partners across India.
References
- MedlinePlus: Dutasteride
- PubChem: Dutasteride
Our formulations of Dutasteride find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to: